In a retrospective cohort study using propensity matching, among patients with obesity, those taking semaglutide had lower ...

When treating obesity, semaglutide may be associated with a reduced fracture risk compared with sleeve gastrectomy.

Fracture risk may be higher after bariatric surgery than after treatment with weight-loss drugs, propensity-score matched ...

Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...

Discover how semaglutide reduces heart attack and stroke risk by 20% in overweight individuals, with benefits appearing ...

In SELECT, semaglutide was associated with a 41% reduction in major CV events within 6 months — ie, before weight loss or ...

The benefit was seen as soon as 3 months. Investigators say there should be no delaying treatment for eligible patients.

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or ...

Weekly 2.4 mg semaglutide was linked to improved liver histology results but did not significantly reduce body pain compared ...